PITTSBURGH — The pain clinic tucked into the corner of a low-slung suburban strip mall was an open secret.
Patients would travel hundreds of miles to see Dr. Andrzej Zielke, eager for what authorities described as a steady flow of prescriptions for the kinds of powerful painkillers that ushered the nation into its worst drug crisis in history.
At least one of Zielke’s patients died of an overdose, and prosecutors say others became so dependent on oxycodone and other opioids they would crowd his office, sometimes sleeping in the waiting room. Some peddled their pills near tumble-down storefronts in addiction-plagued parts of Allegheny County, where deaths by drug overdose reached record levels last year.
But Robert Cessar, a longtime federal prosecutor, was unaware of Zielke until Justice Department officials handed him a binder of data that, he said, confirmed what pill-seekers from as far away as Ohio and Virginia already knew. The doctor who offered ozone therapy and herbal pain remedies was also prescribing highly addictive narcotics to patients who didn’t need them, according to an indictment charging him with conspiracy and unlawfully distributing controlled substances.
Zielke denied he was overprescribing, telling The Associated Press he practiced alternative medicine and many of his patients stopped seeing him when he cut down on pain pills.
His indictment in October was the first by a nationwide group of federal law enforcement officials who, armed with new access to a broader array of prescription drug databases, Medicaid and Medicare figures, coroners’ records and other numbers compiled by the Justice Department, aim to stop pill abuse more quickly.
The department is providing a trove of data to the Opioid Fraud and Abuse Detection Unit, which draws together authorities in 12 regions across the country. It shows which doctors are prescribing the most, how far patients will travel to see them and whether any have died within 60 days of receiving a prescription, among other information.
Authorities have been going after so-called “pill mills” for years, but the new approach brings additional federal resources to bear against the escalating epidemic. Where prosecutors would spend months or longer building a case by relying on erratic informants and only limited data, the number-crunching by analysts provides information they say lets them quickly zero in on a region’s top opioid prescribers.
“This data shines a light we’ve never had before,” Cessar said. “We don’t need to have confidential informants. ... Now, we have someone behind a computer screen who is helping us. That has to put (doctors) on notice that we have new tools.”
